Condition: Aneurysm · Aneurysm, Intracranial · Sponsor: Stryker Neurovascular
The objective of the Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms with Surpass Elite with GUARDian Flow Diverter (GUARD) trial is to evaluate the safety and efficacy of the Surpass Elite with Guardian Flow Diverter System (FDS) in the treatment of unruptured, wide-neck saccular or fusiform, intracranial aneurysms (IAs) located on the internal carotid artery (ICA) or its branches.
This description comes directly from the study's public registry record.
Stacy Phung · 678-469-2428 · stacy.phung@stryker.com
John Strohmeyer · john.strohmeyer@stryker.com
Always discuss trial participation with your own doctor first.
| Carondelet St. Joseph's Hospital | Tucson, Arizona, United States | Recruiting |
| University of California Davis Health | Davis, California, United States | Recruiting |
| Stanford University School of Medicine | Palo Alto, California, United States | Recruiting |
| Lyerly Neurosurgery, an Affiliate of Baptist | Jacksonville, Florida, United States | Recruiting |
| University of Kansas Medical Center | Kansas City, Kansas, United States | Recruiting |
| Lahey Hospital and Medical Center | Burlington, Massachusetts, United States | Recruiting |
| Mount Sinai Health System | New York, New York, United States | Recruiting |
| Stony Brook University Hospital | Stony Brook, New York, United States | Recruiting |
| Cleveland Clinic | Cleveland, Ohio, United States | Recruiting |
| Oregon Health & Science University | Portland, Oregon, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06872684